Indeed, the results in Fig. 1D confirmed enhanced PPARα transcriptional activity following fenofibrate treatment, which was accompanied by increased detection of PPARα in the nuclei of LN-229 Glioma cells (Fig. 1C). The gene discussed is PPARA; the disease is glioma.